RESUMO
BACKGROUND: Yellow-fleshed potatoes biofortified with iron have been developed through conventional breeding, but the bioavailability of iron is unknown. OBJECTIVES: Our objective was to measure iron absorption from an iron-biofortified yellow-fleshed potato clone in comparison with a nonbiofortified yellow-fleshed potato variety. METHODS: We conducted a single-blinded, randomized, crossover, multiple-meal intervention study. Women (n = 28; mean ± SD plasma ferritin 21.3 ± 3.3 µg/L) consumed 10 meals (460 g) of both potatoes, each meal extrinsically labeled with either 58Fe sulfate (biofortified) or 57Fe sulfate (nonfortified), on consecutive days. Iron absorption was estimated from iron isotopic composition in erythrocytes 14 d after administration of the final meal. RESULTS: Mean ± SD iron, phytic acid, and ascorbic acid concentrations in iron-biofortified and the nonfortified potato meals (mg/per 100 mg) were 0.63 ± 0.01 and 0.31 ± 0.01, 39.34 ± 3.04 and 3.10 ± 1.72, and 7.65 ± 0.34 and 3.74 ± 0.39, respectively (P < 0.01), whereas chlorogenic acid concentrations were 15.14 ± 1.72 and 22.52 ± 3.98, respectively (P < 0.05). Geometric mean (95% CI) fractional iron absorption from the iron-biofortified clone and the nonbiofortified variety were 12.1% (10.3%-14.2%) and 16.6% (14.0%-19.6%), respectively (P < 0.001). Total iron absorption from the iron-biofortified clone and the nonbiofortified variety were 0.35 mg (0.30-0.41 mg) and 0.24 mg (0.20-0.28 mg) per 460 g meal, respectively (P < 0.001). CONCLUSIONS: TIA from iron-biofortified potato meals was 45.8% higher than that from nonbiofortified potato meals, suggesting that iron biofortification of potatoes through conventional breeding is a promising approach to improve iron intake in iron-deficient women. The study was registered at www. CLINICALTRIALS: gov as Identifier number NCT05154500.
Assuntos
Ferro , Solanum tuberosum , Humanos , Feminino , Isótopos de Ferro , Peru , Alimentos Fortificados , Sulfatos , Disponibilidade BiológicaRESUMO
BACKGROUND: Early detection of pancreatic ductal adenocarcinoma (PDAC) is an important goal for improving survival. Individuals who meet published guidelines for surveillance may be underidentified, and family communication about risk represents a pathway to increasing participation in surveillance. We investigated the uptake of and barriers to surveillance in at-risk relatives of clinic patients. METHODS: We conducted a retrospective record review of patients with personal or family history of PDAC evaluated over 12 months. The first relative presenting to clinic (proband) reported surveillance status and reasons for nonparticipation for at-risk relatives. Descriptive analyses and Fisher's exact tests were conducted to evaluate differences in surveillance participation. RESULTS: Among 193 at-risk relatives, 21% were in surveillance. The primary reasons for nonparticipation were lack of awareness (36%) and lack of interest (24%). Neither the sex nor the cancer status of probands impacted surveillance. At-risk relatives with familial pancreatic cancer (FPC) who also carried relevant pathogenic germline variants (PGVs) were more likely to undergo surveillance than those with FPC or PGVs alone (P = .003). Among families with PGVs, 59% of relatives potentially eligible for surveillance had not completed genetic testing. CONCLUSION: PDAC surveillance is underutilized in high-risk families. Communication interventions to address informational needs and decisional support could improve outcomes.
Assuntos
Adenocarcinoma , Neoplasias Pancreáticas , Adenocarcinoma/diagnóstico , Adenocarcinoma/epidemiologia , Adenocarcinoma/genética , Predisposição Genética para Doença , Mutação em Linhagem Germinativa , Humanos , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/epidemiologia , Neoplasias Pancreáticas/genética , Estudos RetrospectivosRESUMO
BACKGROUND: Sweetpotato and potato are fast-maturing staple crops and widely consumed in low- and middle-income countries. Conventional breeding to biofortify these crops with iron could improve iron intakes. To our knowledge, iron absorption from sweetpotato and potato has not been assessed. OBJECTIVE: The aim was to assess iron absorption from regular and iron-biofortified orange-fleshed sweetpotato in Malawi and yellow-fleshed potato and iron-biofortified purple-fleshed potato in Peru. METHODS: We conducted 2 randomized, multiple-meal studies in generally healthy, iron-depleted women of reproductive age. Malawian women (n = 24) received 400 g regular or biofortified sweetpotato test meals and Peruvian women (n = 35) received 500 g regular or biofortified potato test meals. Women consumed the meals at breakfast for 2 wk and were then crossed over to the other variety. We labeled the test meals with 57Fe or 58Fe and measured cumulative erythrocyte incorporation of the labels 14 d after completion of each test-meal sequence to calculate iron absorption. Iron absorption was compared by paired-sample t tests. RESULTS: The regular and biofortified orange-fleshed sweetpotato test meals contained 0.55 and 0.97 mg Fe/100 g. Geometric mean (95% CI) fractional iron absorption (FIA) was 5.82% (3.79%, 8.95%) and 6.02% (4.51%, 8.05%), respectively (P = 0.81), resulting in 1.9-fold higher total iron absorption (TIA) from biofortified sweetpotato (P < 0.001). The regular and biofortified potato test meals contained 0.33 and 0.69 mg Fe/100 g. FIA was 28.4% (23.5%, 34.2%) from the regular yellow-fleshed and 13.3% (10.6%, 16.6%) from the biofortified purple-fleshed potato meals, respectively (P < 0.001), resulting in no significant difference in TIA (P = 0.88). CONCLUSIONS: FIA from regular yellow-fleshed potato was remarkably high, at 28%. Iron absorbed from both potato test meals covered 33% of the daily absorbed iron requirement for women of reproductive age, while the biofortified orange-fleshed sweetpotato test meal covered 18% of this requirement. High polyphenol concentrations were likely the major inhibitors of iron absorption. These trials were registered at www.clinicaltrials.gov as NCT03840031 (Malawi) and NCT04216030 (Peru).
Assuntos
Biofortificação , Ipomoea batatas/metabolismo , Ferro/administração & dosagem , Solanum tuberosum/metabolismo , Adulto , Transporte Biológico , Dieta , Feminino , Análise de Alimentos , Alimentos Fortificados , Humanos , Ipomoea batatas/química , Ferro/química , Ferro/metabolismo , Malaui , Peru , Solanum tuberosum/química , Adulto JovemRESUMO
KEY MESSAGE: ß-Carotene content in sweetpotato is associated with the Orange and phytoene synthase genes; due to physical linkage of phytoene synthase with sucrose synthase, ß-carotene and starch content are negatively correlated. In populations depending on sweetpotato for food security, starch is an important source of calories, while ß-carotene is an important source of provitamin A. The negative association between the two traits contributes to the low nutritional quality of sweetpotato consumed, especially in sub-Saharan Africa. Using a biparental mapping population of 315 F1 progeny generated from a cross between an orange-fleshed and a non-orange-fleshed sweetpotato variety, we identified two major quantitative trait loci (QTL) on linkage group (LG) three (LG3) and twelve (LG12) affecting starch, ß-carotene, and their correlated traits, dry matter and flesh color. Analysis of parental haplotypes indicated that these two regions acted pleiotropically to reduce starch content and increase ß-carotene in genotypes carrying the orange-fleshed parental haplotype at the LG3 locus. Phytoene synthase and sucrose synthase, the rate-limiting and linked genes located within the QTL on LG3 involved in the carotenoid and starch biosynthesis, respectively, were differentially expressed in Beauregard versus Tanzania storage roots. The Orange gene, the molecular switch for chromoplast biogenesis, located within the QTL on LG12 while not differentially expressed was expressed in developing roots of the parental genotypes. We conclude that these two QTL regions act together in a cis and trans manner to inhibit starch biosynthesis in amyloplasts and enhance chromoplast biogenesis, carotenoid biosynthesis, and accumulation in orange-fleshed sweetpotato. Understanding the genetic basis of this negative association between starch and ß-carotene will inform future sweetpotato breeding strategies targeting sweetpotato for food and nutritional security.
Assuntos
Regulação da Expressão Gênica de Plantas , Ipomoea batatas/genética , Poliploidia , Locos de Características Quantitativas/genética , Amido/metabolismo , beta Caroteno/metabolismo , Alelos , Meio Ambiente , Estudos de Associação Genética , Fenótipo , Raízes de Plantas/genética , Raízes de Plantas/crescimento & desenvolvimento , Característica Quantitativa HerdávelRESUMO
A dynamic human gastrointestinal (GI) model was used to digest cooked tubers from purple-fleshed Amachi and Leona potato cultivars to study anthocyanin biotransformation in the stomach, small intestine and colonic vessels. Colonic Caco-2 cancer cells and non-tumorigenic colonic CCD-112CoN cells were tested for cytotoxicity and cell viability after 24 h exposure to colonic fecal water (FW) digests (0%, 10%, 25%, 75% and 100% FW in culture media). After 24 h digestion, liquid chromatography-mass spectrometry identified 36 and 15 anthocyanin species throughout the GI vessels for Amachi and Leona, respectively. The total anthocyanin concentration was over thirty-fold higher in Amachi compared to Leona digests but seven-fold higher anthocyanin concentrations were noted for Leona versus Amachi in descending colon digests. Leona FW showed greater potency to induce cytotoxicity and decrease viability of Caco-2 cells than observed with FW from Amachi. Amachi FW at 100% caused cytotoxicity in non-tumorigenic cells while FW from Leona showed no effect. The present findings indicate major variations in the pattern of anthocyanin breakdown and release during digestion of purple-fleshed cultivars. The differing microbial anthocyanin metabolite profiles in colonic vessels between cultivars could play a significant role in the impact of FW toxicity on tumor and non-tumorigenic cells.
Assuntos
Antocianinas/farmacologia , Neoplasias do Colo/química , Tubérculos/química , Solanum tuberosum/química , Adulto , Idoso , Antocianinas/química , Antocianinas/metabolismo , Linhagem Celular Tumoral , Simulação por Computador , Fezes/química , Feminino , Trato Gastrointestinal/fisiologia , Humanos , Masculino , Refeições , Pessoa de Meia-Idade , Modelos BiológicosRESUMO
The bioaccessibility and bioavailability of iron from 12 Andean potato clones were estimated using an in vitro gastrointestinal digestion procedure and the Caco-2 cell line as a model of human intestine, with ferritin formation as a marker of iron absorption. We first showed that 63.7% (for the genotype CIP_311422.016) to 79.0% (for the genotype CIP_311575.003) of the iron is released from the potato tuber matrix during in vitro gastrointestinal digestion and is therefore available at the intestinal level. On average, 32 and 24.5% of the hydrophilic bioactive components, vitamin C and chlorogenic acid, respectively, were also bioaccessible from boiled tubers. Intestinal absorption of intrinsic iron from potato tubers could not be detected using our in vitro Caco-2 cell model. When an extrinsic source of iron (20 µM FeCl3 and 1 mM ascorbic acid) was added to the digestion mixture, iron absorption varied from 1.8 to 8% for the genotypes CIP_311422.016 and CIP_311624.021, respectively, as compared to the reference control. Principal component analysis revealed negative relationships between bioavailable iron values and phenolic concentrations, whereas vitamin C concentrations were positively associated with the ferritin values. Further controlled intervention trials would be needed to conclusively assess the bioavailability of intrinsic iron from potato tubers.
Assuntos
Ácido Ascórbico/metabolismo , Ferro/metabolismo , Fenóis/metabolismo , Solanum tuberosum/metabolismo , Ácido Ascórbico/análise , Disponibilidade Biológica , Células CACO-2 , Carotenoides/análise , Carotenoides/metabolismo , Humanos , Ferro/análise , Modelos Biológicos , Fenóis/análise , Tubérculos/química , Tubérculos/genética , Tubérculos/metabolismo , Solanum tuberosum/química , Solanum tuberosum/genéticaRESUMO
Introducción: La microalbuminuria es un marcador de disfunción vascular generalizada y predictor independiente de riesgo aumentado de morbimortalidad cardiovascular en pacientes con diabetes e hipertensión, así como en la población general Pregunta de investigación: ¿Constituye la Microalbuminuria un factor predictor de la función renal en las mujeres gestantes? Material y Métodos: TIPO DE ESTUDIO: Analitico, prospectivo, longitudinal. UNIVERSO DE ESTUDIO: Mujeres gestantes (75) en control prenatal del Consultorio No 1 del Policlinico Miraflores, de la Caja Nacional de Salud, La Paz, Bolivia. TIEMPO DE ESTUDIO: Marzo a Junio 2014. METODO DEL ESTUDIO, DE RECOLECCION Y ANALISIS DE LA MUESTRA: Examen clínico de la paciente, Llenado de hoja de control prenatal del MSD (CLAP), Recoleccion de orina de 24 horas para determinación de Microalbuminuria. EXAMENES COMPLEMENTARIOS ADICIONALES: Hemograma, Glucemia, Creatinina, Acido urico, TGO, TGP, Examen general de orina. METODOLOGIA ESTADISTICA: Metodos de localización estadística generales (media, desviación standard). Metodos de inferencia: Determinación del valor P y chi square a través de paquete estadístico SPSS V 21.0. VALOR DE SIGNIFICACION ESTADISTICA: P<0,01 Conclusiones: La Microalbuminuria fue un predictor de función renal precoz, identificando que 11,2% de mujeres gestantes de nuestro universo presentaron valores positivos cuando otros marcadores como la creatinina sérica permanecían normales. La prevalencia de la microalbuminuria fue del 11,2%. La Microalbuminuria se correlacionó de forma positiva con estados hipertensivos de la gestación con un valor P = 0,0023. y con diabetes en la gestación estableciéndose un valor P = 0,00187.
Introduction: Microalbuminuria is a marker of generalized vascular dysfunction and an independent predictor of increased risk of cardiovascular morbidity and mortality in patients with diabetes and hypertension as well as in the general population Research Question: Does the Microalbuminuria a predictor of renal function factor in pregnant women?. Material and Methods: TYPE OF STUDY: Analytical, prospective, longitudinal. UNIVERSE STUDY: Pregnant women (75) in the prenatal control of Policlinico Miraflores, Caja Nacional de Salud, La Paz, Bolivia. STUDY TIME. March to June 2014. METHOD OF STUDY COLLECTION AND ANALYSIS OF THE SAMPLE: Clinical examination of the patient, filling sheet prenatal MSD (CLAP), Collection of 24-hour urine for determination of microalbuminuria. ADDITIONAL SUPPLEMENTARY EXAMS: CBC, Blood glucose, creatinine, uric acid, SGOT, SGPT, Urinalysis. STATISTICAL METHODOLOGY: Statistical Methods general location (mean, standard deviation). Inference Methods: Determination of P and chi square value through SPSS V 21.0. VALUE OF STATISTICAL SIGNIFICANCE: P <0.01. Conclusions: Microalbuminuria was an early predictor of renal function, identifying that 11.2% of pregnant women in our universe had positive values when other markers such as serum creatinine remained normal. The prevalence of microalbuminuria was 11.2%. The Microalbuminuria is positively correlated with hypertensive states of pregnancy at P = 0.0023., And gestational diabetes establishing a value P = 0.00187.